Compare Multi Agro Gemilang Plantation Tbk. (MAGP) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multi Agro Gemilang Plantation Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Multi Agro Gemilang Plantation Tbk. trades at Rp50 (market cap 450B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Multi Agro Gemilang Plantation Tbk. is far larger — about 4.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MAGP | SCPI | |
|---|---|---|
Market Cap | 450B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multi Agro Gemilang Plantation Tbk.
Multi Agro Gemilang Plantation, PT (the Company) was established as PT Jo Perkasa Agro Techonologies based on the Notarial Deed No. 4 dated April 13, 2005 of Herlina Pakpahan, SH., notary in Jakarta.
Read more on MAGP →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
